The P/E ratio for Amphastar Pharmaceuticals stock stands at 14.69 as of Oct 22, 2024. This is calculated based on the current EPS of $3.43 and the stock price of $50.38 per share. A decrease of 8% has been recorded in the PE ratio compared to the average of 15.9 of the past four quarters.
Over the last nine years, the average PE ratio of Amphastar Pharmaceuticals has been 139.19. The current 14.69 price-to-earnings ratio is 89% less than the historical average. In the past nine years, AMPH's PE ratio reached its highest point in the Mar 2016 quarter at 1,200, with a price of $12 and an EPS of $0.01. The Jun 2024 quarter saw the lowest point at 11.66, with a price of $40 and an EPS of $3.43.
Maximum annual increase: 3,513.64% in 2020
Maximum annual decrease: -97.33% in 2021
Year | PE ratio | Change |
---|---|---|
2023 | 21.7 | 45.64% |
2022 | 14.9 | -16.85% |
2021 | 17.92 | -97.33% |
2020 | 670.33 | 3,513.64% |
2019 | 18.55 | N/A |
2018 | N/A | N/A |
2017 | 240.5 | 187.23% |
2016 | 83.73 | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
Currently, AMPH's PE ratio is lower than the 3, 5 and 10-year averages.
Stock name | PE ratio | Market cap |
---|---|---|
AMPH Amphastar Pharmaceuticals Inc | 14.53 | $2.43B |
SCYX Scynexis Inc | N/A | $56.78M |
RGLS Regulus Therapeutics Inc | N/A | $94.93M |
MRNS Marinus Pharmaceuticals Inc | N/A | $93.09M |
The price to earnings ratio for AMPH stock is 14.69 as of Oct 22, 2024.
The average PE ratio for AMPH stock over the past 3 years is 18.26.
The average PE ratio for AMPH stock over the past 5 years is 88.14.
The highest quarterly PE ratio in the last nine years has been 1,200 and it was in the Mar 2016 quarter.
The current price to earnings ratio of AMPH is 89% lower than the 9-year historical average.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Oct 22, 2024), Amphastar Pharmaceuticals's stock price is $50.38. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $3.43. Therefore, Amphastar Pharmaceuticals's price to earnings ratio for today is 14.69. PE RATIO(14.69) = STOCK PRICE($50.38) / TTM EPS($3.43)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.